GlassScriptPhysician profile
Margot G Abundis
NPI 1396746194
$3,393.32
in general payments reported to CMS, 2019-2025
36 companies · $576 in 2025
The $576 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $204 · 2021: $258 · 2022: $770 · 2023: $544 · 2024: $434 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,460 · Education: $93.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,459.82 |
| Education | $93.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $481.48 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $375.10 | 2019-2025 | Veozah, Myrbetriq |
| Aspira Women'S Health INC | $277.15 | 2019-2025 | Ova1 |
| Mayne Pharma Commercial LLC | $225.09 | 2021-2025 | |
| Organon LLC | $182.90 | 2021-2025 | Nexplanon |
| Myovant Sciences INC. | $167.87 | 2021-2022 | |
| Coopersurgical, INC. | $144.72 | 2019-2024 | Paragard T 380a |
| Lupin INC. | $138.86 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $118.90 | 2023-2024 | Myfembree |
| Therapeuticsmd, INC. | $117.19 | 2019-2022 | |
| Daiichi Sankyo INC. | $113.15 | 2019-2025 | Injectafer |
| Medtronic, INC. | $90.33 | 2024 | V-Loc 180 |
| Bayer Healthcare Pharmaceuticals INC. | $88.85 | 2019-2023 | |
| Evofem Biosciences, INC. | $86.31 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $74.65 | 2020-2024 | Gardasil 9, Gardasil |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $66.54 | 2024 | |
| Channel Medsystems, INC. | $66.35 | 2025 | |
| Exact Sciences Corporation | $63.62 | 2023-2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $60.02 | 2022-2023 | Coolseal Generator |
| Vertical Pharmaceuticals, LLC | $47.70 | 2019 | |
| Shield Therapeutics INC | $45.18 | 2022-2025 | Accrufer |
| Pfizer INC. | $44.17 | 2023-2025 | |
| Amgen INC. | $41.90 | 2019-2022 | |
| Exeltis, USA INC. | $38.39 | 2019-2020 | |
| Agile Therapeutics, INC. | $33.73 | 2022 | |
| Boston Scientific Corporation | $29.38 | 2024 | |
| Baxter Healthcare | $26.85 | 2025 | Hillrom - Monarch Airway Clearance System |
| Integra Lifesciences Corporation | $20.28 | 2025 | Integra, Omnigraft, Surgimend |
| Millicent US INC | $18.09 | 2024 | Intrarosa, Femring |
| Avion Pharmaceuticals | $18.06 | 2023 | Balcoltra |
| Dysis Medical, INC. | $17.83 | 2020 | |
| Seqirus USA INC | $17.39 | 2025 | Flucelvax, Fluad |
| Mission Pharmacal Company | $16.95 | 2019 | |
| Axonics, INC. | $15.04 | 2022 | |
| Ascend Therapeutics US, LLC | $14.64 | 2022 | |
| Meditrina | $8.66 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margot Abundis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.